We are live on ! Find out more
CA

Capital Advantage Portfolio holdings

AUM $834M Turnover 14.46%
1-Year Est. Return 15.6%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+15.6%
3 Year Est. Return
+49.19%
5 Year Est. Return
+46.21%
10 Year Est. Return
–
AUM
$243M
AUM Growth
+$50.7M
Cap. Flow
+$51M
Cap. Flow %
21.03%
Top 10 Hldgs %
70.13%
Holding
71
New
15
Increased
22
Reduced
14
Closed
4
Avg Time Held
0.7 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.6 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NOC icon
26
Northrop Grumman
NOC
$70.4B
$1.05M 0.43%
7,129
– –
2013 Q4
4 quarters
RTX icon
27
RTX Corp
RTX
$251B
$950K 0.39%
13,128
– –
2013 Q4
4 quarters
MINT icon
28
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18.6B
$908K 0.37%
8,984
-8,003
-47% -$811K
2013 Q4
4 quarters
JNJ icon
29
Johnson & Johnson
JNJ
$612B
$898K 0.37%
8,592
+375
+5% +$39.5K
2013 Q4
4 quarters
MSFT icon
30
Microsoft
MSFT
$3.96T
$863K 0.36%
18,580
-470
-2% -$22.1K
2013 Q4
4 quarters
PG icon
31
Procter & Gamble
PG
$364B
$806K 0.33%
8,849
+251
+3% +$22.1K
2013 Q4
4 quarters
T icon
32
AT&T
T
$158B
$775K 0.32%
30,547
+1,099
+4% +$28.5K
2013 Q4
4 quarters
SCHM icon
33
Schwab US Mid-Cap ETF
SCHM
$14.4B
$705K 0.29%
+52,017
New +$685K
2014 Q4
0 quarters
MCK icon
34
McKesson
MCK
$114B
$633K 0.26%
3,050
– –
2013 Q4
4 quarters
CSCO icon
35
Cisco
CSCO
$448B
$543K 0.22%
19,509
-2,098
-10% -$54.2K
2013 Q4
4 quarters
SCHG icon
36
Schwab US Large-Cap Growth ETF
SCHG
$64.1B
$474K 0.2%
+73,152
New +$461K
2014 Q4
0 quarters
PEP icon
37
PepsiCo
PEP
$176B
$451K 0.19%
4,771
+306
+7% +$29.3K
2013 Q4
4 quarters
PFE icon
38
Pfizer
PFE
$166B
$446K 0.18%
15,079
+551
+4% +$15.8K
2013 Q4
4 quarters
KMI icon
39
Kinder Morgan
KMI
$74.3B
$442K 0.18%
+10,447
New +$411K
2014 Q4
0 quarters
IBM icon
40
IBM
IBM
$215B
$394K 0.16%
2,567
+1,089
+74% +$173K
2013 Q4
4 quarters
AMZN icon
41
Amazon
AMZN
$2.74T
$386K 0.16%
24,880
– –
2013 Q4
4 quarters
MCD icon
42
McDonald's
MCD
$169B
$351K 0.14%
3,744
– –
2013 Q4
4 quarters
MRK icon
43
Merck
MRK
$364B
$331K 0.14%
6,103
+5
+0.1% +$279
2013 Q4
4 quarters
VZ icon
44
Verizon
VZ
$185B
$330K 0.14%
7,058
+634
+10% +$31K
2013 Q4
4 quarters
AMGN icon
45
Amgen
AMGN
$230B
$327K 0.13%
2,055
+1
+0% +$156
2013 Q4
4 quarters
ADP icon
46
Automatic Data Processing
ADP
$111B
$302K 0.12%
+3,624
New +$294K
2014 Q4
0 quarters
QCOM icon
47
Qualcomm
QCOM
$184B
$282K 0.12%
3,793
-102
-3% -$7.46K
2013 Q4
4 quarters
WBA icon
48
DELISTED
Walgreens Boots Alliance
WBA
$282K 0.12%
3,698
– –
2013 Q4
4 quarters
UNP icon
49
Union Pacific
UNP
$170B
$280K 0.12%
2,352
– –
2014 Q1
3 quarters
KO icon
50
Coca-Cola
KO
$395B
$259K 0.11%
6,144
+224
+4% +$9.57K
2014 Q2
2 quarters

Similar funds

Capital Advantage's Q4 2014 Portfolio in Review

As of Q4 2014, Capital Advantage held 71 positions worth $243M, up 26% from $192M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Capital Advantage deployed $51M of net new capital in Q4 2014, opening 15 new positions and adding to 22 existing holdings. Its largest new stake was Vanguard Morningstar Mega Cap Value ETF: 296,319 shares worth $18M.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 87% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Guggenheim BulletShares 2016 Corporate Bond ETF, an estimated $4.1M trimmed.

  • Capital Advantage's largest Q4 2014 buy was Vanguard Morningstar Mega Cap Value ETF: 296,319 shares worth $18M.
  • Capital Advantage added most to iShares Core S&P 500 ETF in Q4 2014, an estimated $11.3M increase.
  • Capital Advantage's biggest Q4 2014 reduction was Guggenheim BulletShares 2016 Corporate Bond ETF, cutting an estimated $4.1M.
  • Capital Advantage fully exited Teva Pharmaceutical Industries Limited in Q4 2014, selling an estimated $288K.
  • Capital Advantage's ten largest holdings make up 70% of its $243M portfolio in Q4 2014.
  • Capital Advantage opened 15 new positions and closed 4 in Q4 2014.
  • Capital Advantage's portfolio value rose 26% quarter-over-quarter to $243M.

Based on Capital Advantage's 13F filing for Q4 2014, filed 15 May 2015.